Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trial

Journal of Hepatology

Volumn 62, Issue 1, 2015, Pages 190-197

  Argo, Curtis K ^a   Patrie, James T ^b   Lackner, Carolin ^c   Henry, Thomas D ^a   De Lange, Eduard E ^a   Weltman, Arthur L ^b   Shah, Neeral L ^a   Al Osaimi, Abdullah M ^a   Pramoonjago, Patcharin ^d   Jayakumar, Saumya ^a,e   Binder, Lukas P ^c   Simmons Egolf, Winsor D ^a   Burks, Sandra G ^a   Bao, Yongde ^d   Taylor, Ann Gill ^b   Rodriguez, Jessica ^b   Caldwell, Stephen H ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITY OF VIRGINIA   (United States)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cardiorespiratory fitness; Exercise; Fatty liver; N 3 fatty acid; Obesity; Steatohepatitis

Indexed keywords

FAT; FISH OIL; OMEGA 3 FATTY ACID; PLACEBO;

ADULT; AGE; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; EXERCISE TOLERANCE; FAT CONTENT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; METABOLIC REGULATION; MORPHOMETRICS; NONALCOHOLIC FATTY LIVER; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL COUNSELING; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION; AGED; BIOPSY; DRUG EFFECTS; ENERGY METABOLISM; FOLLOW UP; LIVER; METABOLISM; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; AGED; BIOPSY; DOUBLE-BLIND METHOD; ENERGY METABOLISM; FATTY ACIDS, OMEGA-3; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RETROSPECTIVE STUDIES;

EID: 84918554640     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.08.036     Document Type: Article

References (38)

1. M. Lazo, and J.M. Clark The epidemiology of nonalcoholic fatty liver disease: a global perspective Semin Liver Dis 28 2008 339 350
2. A.P. Simopoulos Importance of the omega-6/omega-3 balance in health and disease: evolutionary aspects of diet World Rev Nutr Diet 102 2011 10 21
3. Letter responding to a request to reconsider the qualified claim for a dietary supplement health claim for omega-3 fatty acids and coronary heart disease. RE: Health Claim Petition: Omega-3 fatty acids and reduced risk of coronary heart disease (Docket No. 2003Q-0401). September 8, 2004. Accessed on April 19, 2013.
4. H. Cortez-Pinto, L. Jesus, and H. Barros How different is the dietary pattern in non-Alcoholic steatohepatitis patients? Clin Nutr 25 2006 816 823
5. G. Musso, R. Gambino, and F. De Michieli Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis Hepatology 37 2003 909 916
6. S. Zelber-Sagi, D. Nitzan-Kaluski, and R. Goldsmith Long term nutritional intake and the risk for non-Alcoholic fatty liver disease (NAFLD): a population based study J Hepatol 47 2007 711 717
7. J. Araya, R. Rodrigo, and L.A. Videla Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-Alcoholic fatty liver disease Clin Sci 106 2004 635 643
8. P. Puri, R.A. Baillie, and M.M. Wiest A lipidomic analysis of nonalcoholic fatty liver disease Hepatology 46 2007 1081 1090
9. M. Borkman, L.H. Storlien, and D.A. Pan The relationship between insulin sensitivity and the fatty acid composition of skeletal muscle N Engl J Med 328 1993 238 244
10. P. Pettinelli, T. del Pozo, and J. Araya Enhancement in liver SREBP-1c/PPAR-Alpha ratio and steatosis in obese patients: correlations with insulin resistance and n3 long-chain polyunsaturated fatty acid depletion Biochim Biophys Acta-Mol Basis Dis 1792 2009 1080 1086
11. G.S. Masteron, J.N. Plevris, and P.C. Hayes Review article: omega-3 fatty acids - A promising novel therapy for non-Alcoholic fatty liver disease Aliment Pharmacol Ther 31 2010 679 692
12. H.M. Parker, N.A. Johnson, and C.A. Burdon Omega-3 supplementation and non-Alcoholic fatty liver disease: a systematic review and meta-Analysis J Hepatol 56 2012 944 951
13. N.A. Johnson, T. Sachinwalla, and D.W. Walton Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss Hepatology 50 2009 1105 1112
14. B.A. Neuschwander-Tetri, and S.H. Caldwell Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference Hepatology 37 2003 1202 1219
15. C.A. Matteoni, Z.M. Younossi, and T. Gramlich Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1999 1413 1419
16. P.M. Kris-Etherton, W.S. Harris, and L.J. Appel AHA scientific statement: fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease Circulation 106 2002 2747 2757
17. B.E. Ainsworth, W.L. Haskell, and M.C. Whitt Compendium of physical activities: an update of activity codes and MET intensities Med Sci Sports Exerc 32 2000 S498 S504
18. M.F. Abdelmalek, A. Suzuki, and C. Guy NASH Clinical Research Network (CRN). Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease Hepatology 51 2010 1961 1971
19. S. Caldwell, Y. Ikura, and D. Dias Hepatocellular ballooning in NASH J Hepatol 53 2010 719 723
20. C. Lackner, M. Gogg-Kamerer, and K. Zatloukal Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis J Hepatol 48 2008 821 828
21. D.E. Kleiner, E.M. Brunt, and M. Van Natta NASH Clinical Research Network (CRN). Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
22. E.M. Brunt, C.G. Janney, and A.M. Di Bisceglie Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 1999 2467 2474
23. Z.M. Younossi, M. Stepanova, and N. Rafiq Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality Hepatology 53 2011 1874 1882
24. D.E. Kleiner, M.M. Yah, and C.D. Guy Creation of a continuous visual scale of ballooned hepatocytes in non-Alcoholic fatty liver disease Hepatology 48 2008 815A
25. R. Juluri, R. Vuppalanchi, and J. Olson Generalizability of the NASH-CRN histologic scoring system for nonalcoholic fatty liver disease J Clin Gastroenterol 45 2011 55 58
26. S. Gawrieh, D.M. Knoedler, and K. Saeian Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology Ann Diagn Pathol 15 2011 19 24
27. D.A. Raptis, M.A. Fischer, and R. Graf MRI: the new reference standard in quantifying hepatic steatosis? Gut 61 2012 117 127
28. S.M. Noworolski, M.M. Lam, and R.B. Merriman Liver steatosis: concordance of MR imaging and MR spectroscopic data with histologic grade Radiology 264 2012 88 96
29. G. Perseghin, A. Caumo, and M. Caloni Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals J Clin Endocrinol Metab 86 2001 4776 4781
30. A. Elizondo, J. Araya, and R. Rodrigo Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-Alcoholic fatty liver disease Biol Res 41 2008 59 68
31. W.D. Dupont, and W.D. Plummer Power and sample size calculations. A review and computer program Control Clin Trials 11 1990 116 128
32. E.M. Brunt, D.E. Kleiner, and L.A. Wilson NASH Clinical Research Network. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings Hepatology 53 2011 810 820
33. A.J. Sanyal, N. Chalasani, and K.V. Kowdley NASH Clinical Research Network. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis N Engl J Med 362 2010 1675 1685
34. M. Sekiya, N. Yahagi, and T. Matsuzaka Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression Hepatology 38 2003 1529 1539
35. I.P. Emilia, G.C. Farrell, and G. Roberston Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice Hepatology 38 2003 123 132
36. S. Endres, R. Ghorbani, and V.E. Kelley The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells N Engl J Med 320 1989 265 271
37. R.M. Green NASH-hepatic metabolism and not simply the metabolic syndrome Hepatology 38 2003 14 17
38. A.J. Sanyal, M.F. Abdelmalek, A. Suzuki, O.W. Cummings, and M. Chojkier No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial Gastroenterology 147 2014 377 384